Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Impact of hormone replacement therapy use on mammographic screening outcomes.

Beckmann KR, Farshid G, Roder DM, Hiller JE, Lynch JW.

Cancer Causes Control. 2013 Jul;24(7):1417-26. doi: 10.1007/s10552-013-0221-1. Epub 2013 May 7.

PMID:
23649232
2.

Trends in detection of invasive cancer and ductal carcinoma in situ at biennial screening mammography in Spain: a retrospective cohort study.

Román M, Rué M, Sala M, Ascunce N, Baré M, Baroja A, De la Vega M, Galcerán J, Natal C, Salas D, Sánchez-Jacob M, Zubizarreta R, Castells X; Cumulative False Positive Risk Group.

PLoS One. 2013 Dec 23;8(12):e83121. doi: 10.1371/journal.pone.0083121. eCollection 2013.

3.

Incidence of invasive breast cancer and ductal carcinoma in situ in a screening program by age: should older women continue screening?

Erbas B, Amos A, Fletcher A, Kavanagh AM, Gertig DM.

Cancer Epidemiol Biomarkers Prev. 2004 Oct;13(10):1569-73.

4.

Screen detection of ductal carcinoma in situ and subsequent incidence of invasive interval breast cancers: a retrospective population-based study.

Duffy SW, Dibden A, Michalopoulos D, Offman J, Parmar D, Jenkins J, Collins B, Robson T, Scorfield S, Green K, Hall C, Liao XH, Ryan M, Johnson F, Stevens G, Kearins O, Sellars S, Patnick J.

Lancet Oncol. 2016 Jan;17(1):109-14. doi: 10.1016/S1470-2045(15)00446-5. Epub 2015 Dec 5. Erratum in: Lancet Oncol. 2016 Feb;17(2):e46.

5.

Hormone replacement therapy and mammographic screening outcomes in Western Australia.

Crouchley K, Wylie E, Khong E.

J Med Screen. 2006;13(2):93-7.

PMID:
16792833
6.

Detection of ductal carcinoma in situ in women undergoing screening mammography.

Ernster VL, Ballard-Barbash R, Barlow WE, Zheng Y, Weaver DL, Cutter G, Yankaskas BC, Rosenberg R, Carney PA, Kerlikowske K, Taplin SH, Urban N, Geller BM.

J Natl Cancer Inst. 2002 Oct 16;94(20):1546-54.

7.

Screening mammography use among current, former, and never hormone therapy users may not explain recent declines in breast cancer incidence.

Buist DS, Walker R, Bowles EJ, Carney PA, Taplin SH, Onega T, Kerlikowske K, Clinton W, Miglioretti DL.

Cancer Epidemiol Biomarkers Prev. 2012 May;21(5):720-7. doi: 10.1158/1055-9965.EPI-11-1115. Epub 2012 Feb 1.

8.
9.

Trends in incidence and detection of advanced breast cancer at biennial screening mammography in The Netherlands: a population based study.

Nederend J, Duijm LE, Voogd AC, Groenewoud JH, Jansen FH, Louwman MW.

Breast Cancer Res. 2012 Jan 9;14(1):R10.

10.

Hormone replacement therapy, percent mammographic density, and sensitivity of mammography.

Kavanagh AM, Cawson J, Byrnes GB, Giles GG, Marr G, Tong B, Gertig DM, Hopper JL.

Cancer Epidemiol Biomarkers Prev. 2005 May;14(5):1060-4.

11.

Early detection of breast cancer through population-based mammographic screening in Asian women: a comparison study between screen-detected and symptomatic breast cancers.

Chuwa EW, Yeo AW, Koong HN, Wong CY, Yong WS, Tan PH, Ho JT, Wong JS, Ho GH.

Breast J. 2009 Mar-Apr;15(2):133-9. doi: 10.1111/j.1524-4741.2009.00687.x.

PMID:
19292798
12.

Influence of patterns of hormone replacement therapy use and mammographic density on breast cancer detection.

Chiarelli AM, Kirsh VA, Klar NS, Shumak R, Jong R, Fishell E, Yaffe MJ, Boyd NF.

Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10):1856-62.

13.

Stage-specific breast cancer incidence rates among participants and non-participants of a population-based mammographic screening program.

Hofvind S, Lee CI, Elmore JG.

Breast Cancer Res Treat. 2012 Aug;135(1):291-9. doi: 10.1007/s10549-012-2162-x. Epub 2012 Jul 26.

14.

Epidemiology of ductal carcinoma in situ.

Kerlikowske K.

J Natl Cancer Inst Monogr. 2010;2010(41):139-41. doi: 10.1093/jncimonographs/lgq027. Review.

PMID:
20956818
15.

Breast carcinoma in situ: risk factors and screening patterns.

Claus EB, Stowe M, Carter D.

J Natl Cancer Inst. 2001 Dec 5;93(23):1811-7.

16.

Overdiagnosis among women attending a population-based mammography screening program.

Falk RS, Hofvind S, Skaane P, Haldorsen T.

Int J Cancer. 2013 Aug 1;133(3):705-12. doi: 10.1002/ijc.28052. Epub 2013 Feb 25.

17.

Breast cancer in Singapore: some perspectives.

Jara-Lazaro AR, Thilagaratnam S, Tan PH.

Breast Cancer. 2010;17(1):23-8. doi: 10.1007/s12282-009-0155-3. Epub 2009 Aug 22.

PMID:
19701678
19.

Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: longitudinal results from a cohort study.

Partridge A, Adloff K, Blood E, Dees EC, Kaelin C, Golshan M, Ligibel J, de Moor JS, Weeks J, Emmons K, Winer E.

J Natl Cancer Inst. 2008 Feb 20;100(4):243-51. doi: 10.1093/jnci/djn010. Epub 2008 Feb 12.

20.
Items per page

Supplemental Content

Write to the Help Desk